Torapsel

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NameTorapsel

Drug Alias Name重组P-选择素糖蛋白配体融合蛋白rPSGL-IgPSGL-1Igrecombinant P-selectin glycoprotein ligand Ig fusion proteinYSPSL

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein

Mechanisms of ActionP-selectin inhibitors

TargetsP-selectin

Therapy Area/IndicationsReperfusion InjuryKidney DiseasesLiver Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsReperfusion InjuryKidney DiseasesLiver Diseases

ATC CodeN/A